Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Real-World Assessment of Prophylactic Anakinra on Neurotoxicity and Cytokine Release Syndrome after CD19 Chimeric Antigen Receptor T-Cell Therapy in Relapsed and Refractory B-Cell Lymphoma: An Inverse Probability of Treatment Weighting Analysis.
Journal: Transplantation and cellular therapy
Published: March 25, 2026
IL-36γ armored CAR T cells reprogram neutrophils to induce endogenous antitumor immunity.
Journal: Cancer cell
Published: April 29, 2025
TYRP1 directed CAR T cells control tumor progression in preclinical melanoma models.
Journal: Molecular therapy. Oncology
Published: April 05, 2024
CAR-engineered lymphocyte persistence is governed by a FAS ligand/FAS auto-regulatory circuit.
Journal: bioRxiv : the preprint server for biology
Published: March 11, 2024
CAR-engineered lymphocyte persistence is governed by a FAS ligand-FAS autoregulatory circuit.
Journal: Nature cancer
Published: February 23, 2024
Multipurposing CARs: Same engine, different vehicles.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: August 17, 2021
Engineering strategies to overcome the current roadblocks in CAR T cell therapy.
Journal: Nature reviews. Clinical oncology
Published: October 24, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026